Treasuries jumped as weak jobs and manufacturing data bolstered bets on Federal Reserve rate cuts. Stocks extended their ...

Retail chatter around Apellis Pharmaceuticals spiked Thursday after Goldman Sachs raised its price target to $26 from $24, citing strong quarterly performance and long-term growth potential through ...

Lam Research (LRCX) beat earnings expectations and raised its guidance, thanks to strong demand from China. Shares fell due to concerns over this growth's sustainability.

Figma shares surged nearly 158% in their market debut on Thursday, valuing the design software maker at about $50 billion and ...

The total market cap of the Magnificent Seven is larger than China's economy, and nearly as large as the Eurozone's and U.K.'s economies combined.

Nebius is surging with ARR momentum, bullish options flow, and Goldman’s $68 target as Q2 revenue nears a key breakout. Find ...

"Recent flow data tells a similar story: purchasing of Mag7+ stocks as a share of total inflows have rebounded and then stabilized, suggesting that while meme stock flows made headlines, they didn't ...

Goldman Sachs' Q2 2025 results validate its strategic shift to core businesses, with improved margins. Read why I rate GS ...

Operating cash flow for Q1 was US$928 million, while investment income grew to US$491 million. The improvement in Q2 earnings highlights a recovery from the first quarter’s catastrophe-driven ...

Societe Generale's shares surged on Thursday as the French bank raised its annual profit target after a rebound in its French ...

HB Wealth Management LLC has significantly increased its investment in The Goldman Sachs Group (GS), raising its holdings by ...

Apartment vacancies are still rising due to a glut of new apartments hitting the market in the past few years. Rents are down ...